Duan R, Wen Z, Zhang T, Liu J, Feng T, Ren T
Clin Exp Med. 2025; 25(1):74.
PMID: 40047952
PMC: 11885319.
DOI: 10.1007/s10238-025-01590-6.
Liu L, Meng Z, Yan J
PLoS One. 2025; 20(2):e0318984.
PMID: 39913618
PMC: 11801641.
DOI: 10.1371/journal.pone.0318984.
Li X, Lampson K, Ahles T, Root J, Li Q, Li Y
Curr Oncol. 2025; 32(1).
PMID: 39851943
PMC: 11763785.
DOI: 10.3390/curroncol32010027.
Downs T, Whiteside E, Denham J, Mills D, Bliss E
J Clin Med. 2025; 13(24).
PMID: 39768764
PMC: 11678850.
DOI: 10.3390/jcm13247841.
Goto T, Saligan L, Juneau P, Gonsalves S, Rio C, Graves L
Cancer Med. 2024; 13(12):e7255.
PMID: 39185749
PMC: 11192644.
DOI: 10.1002/cam4.7255.
Correlation between cancer-related cognitive impairment and resting cerebral glucose metabolism in patients with ovarian cancer.
Wang L, Hu S, Yao Z, Xue M, Lu Z, Xiao-Ju Z
Heliyon. 2024; 10(14):e34106.
PMID: 39113970
PMC: 11305194.
DOI: 10.1016/j.heliyon.2024.e34106.
Nose-to-brain Drug Delivery System: An Emerging Approach to Chemotherapy-induced Cognitive Impairment.
Jannapu Reddy S, Mutalik S, Viswanatha G, Kumar G, John J, Chamallamudi M
Pharm Nanotechnol. 2024; 13(1):212-238.
PMID: 38757164
DOI: 10.2174/0122117385291482240426101519.
Effects of different exercise interventions on chemotherapy-related cognitive impairment in patients with breast cancer: a study protocol for systematic review and network meta-analysis.
Dong Y, Huang H, Wang A
BMJ Open. 2024; 14(4):e078934.
PMID: 38631832
PMC: 11029385.
DOI: 10.1136/bmjopen-2023-078934.
Natural products for the treatment of chemotherapy-related cognitive impairment and prospects of nose-to-brain drug delivery.
He Y, Zhou C, Jiang S, Lan W, Zhang F, Tao X
Front Pharmacol. 2024; 15:1292807.
PMID: 38348396
PMC: 10859466.
DOI: 10.3389/fphar.2024.1292807.
Role of Chinese Acupuncture in the Treatment for Chemotherapy-Induced Cognitive Impairment in Older Patients With Cancer: Protocol for a Randomized Controlled Trial.
Zhao S, Zhang J, Wan H, Tao C, Hu M, Liang W
JMIR Res Protoc. 2024; 13:e53853.
PMID: 38329790
PMC: 10884956.
DOI: 10.2196/53853.
Intranasally Administered MSC-Derived Extracellular Vesicles Reverse Cisplatin-Induced Cognitive Impairment.
Milutinovic B, Mahalingam R, Mendt M, Arroyo L, Seua A, Dharmaraj S
Int J Mol Sci. 2023; 24(14).
PMID: 37511623
PMC: 10380450.
DOI: 10.3390/ijms241411862.
Tumor-mediated microbiota alteration impairs synaptic tagging/capture in the hippocampal CA1 area via IL-1β production.
Zhu Y, Mei Y, Baby N, Teo H, Binte Hanafi Z, Salleh S
Commun Biol. 2023; 6(1):685.
PMID: 37400621
PMC: 10318068.
DOI: 10.1038/s42003-023-05036-1.
An Evaluation of the Multifactorial Model of Cancer-Related Cognitive Impairment.
Oppegaard K, Mayo S, Armstrong T, Kober K, Anguera J, Wright F
Nurs Res. 2023; 72(4):272-280.
PMID: 37104681
PMC: 10330009.
DOI: 10.1097/NNR.0000000000000660.
Associations between disrupted functional brain network topology and cognitive impairment in patients with rectal cancer during chemotherapy.
Guo Y, Liu S, Yan F, Yin N, Ni J, Li C
Front Oncol. 2022; 12:927771.
PMID: 36505777
PMC: 9731768.
DOI: 10.3389/fonc.2022.927771.
Aldehyde dehydrogenase 2 polymorphism is associated with chemotherapy-related cognitive impairment in patients with breast cancer who receive chemotherapy.
Yao S, Li W, Liu S, Cai Y, Zhang Q, Tang L
Cancer Med. 2022; 12(5):5209-5221.
PMID: 36200595
PMC: 10028021.
DOI: 10.1002/cam4.5319.
Impact of integrated yoga therapy on cognitive impairment and cardiac dysfunction in relation to quality of life in breast cancer patients undergoing chemotherapy: Study protocol for a two-arm randomized controlled trial.
Inbaraj G, Sathyaprabha T, Udupa K, Ram A, Patil S, Rajeswaran J
Front Oncol. 2022; 12:955184.
PMID: 36185291
PMC: 9524232.
DOI: 10.3389/fonc.2022.955184.
The correlation between neutrophil-to-lymphocyte ratio, carcinoembryonic antigen, and carbohydrate antigen 153 levels with chemotherapy-related cognitive impairment in early-stage breast cancer patients.
Yu S, Zhao J, Wang M, Cheng G, Li W, Tang L
Front Med (Lausanne). 2022; 9:945433.
PMID: 36091709
PMC: 9453200.
DOI: 10.3389/fmed.2022.945433.
Chemotherapy-induced functional brain abnormality in colorectal cancer patients: a resting-state functional magnetic resonance imaging study.
Liu S, Guo Y, Ni J, Yin N, Li C, Pan X
Front Oncol. 2022; 12:900855.
PMID: 35924154
PMC: 9339615.
DOI: 10.3389/fonc.2022.900855.
Electroacupuncture for Cancer-Related Cognitive Impairment: A Clinical Feasibility Study.
Lyu Y, Lee H, Park H, Kwon O, Kim A, Jung I
Integr Cancer Ther. 2022; 21:15347354221098983.
PMID: 35608027
PMC: 9134458.
DOI: 10.1177/15347354221098983.
Mapping cognitive deficits in cancer patients after chemotherapy: An Activation Likelihood Estimation meta-analysis of task-related fMRI studies.
Saward J, Ellis E, Cobden A, Caeyenberghs K
Brain Imaging Behav. 2022; 16(5):2320-2334.
PMID: 35366180
PMC: 9581855.
DOI: 10.1007/s11682-022-00655-4.